Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1980 Nov;43(11):995–998. doi: 10.1136/jnnp.43.11.995

Evaluation of the erythrocyte-UFA (E-UFA) mobility test for the diagnosis of multiple sclerosis.

J Cuypers, H Reddemann
PMCID: PMC490750  PMID: 7441283

Abstract

The absolute electrophoretic mobility of red blood cells was examined before and after the addition of linoleic acid. The determinations were performed with a Zeiss cytopherometer. The blood was taken from 22 patients with multiple sclerosis in different phases of their disease. A group of 17 patients with other neurological diseases and three apparently healthy subjects served as controls. Our results show that the mobility of red blood cells was either accelerated or inhibited in the presence of linoleic acid, both in the multiple sclerosis patients as well as in the control group. The increase or inhibition of the absolute mobility was small and randomly distributed. The value of this so-called E-UFA test (erythrocyte-unsaturated fatty acid) as a specific diagnostic test for multiple sclerosis is not confirmed by our results.

Full text

PDF
995

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agranoff B. W., Goldberg D. Diet and the geographical distribution of multiple sclerosis. Lancet. 1974 Nov 2;2(7888):1061–1066. doi: 10.1016/s0140-6736(74)92163-1. [DOI] [PubMed] [Google Scholar]
  2. Bates D., Fawcett P. R., Shaw D. A., Weightman D. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J. 1978 Nov 18;2(6149):1390–1391. doi: 10.1136/bmj.2.6149.1390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Belin J., Pettet N., Smith A. D., Thompson R. H., Zilkha K. J. Linoleate metabolism in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1971 Feb;34(1):25–29. doi: 10.1136/jnnp.34.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Davison A. N., Cuzner M. L. Immunochemistry and biochemistry of myelin. Br Med Bull. 1977 Jan;33(1):60–66. doi: 10.1093/oxfordjournals.bmb.a071398. [DOI] [PubMed] [Google Scholar]
  5. Draper P., Huang Y. S., Shapcott D., Lemieux B., Brennan M., Barbeau A., Davignon J. Erythrocyte membrane lipids in Friedreich's ataxia. Can J Neurol Sci. 1979 May;6(2):291–294. doi: 10.1017/s0317167100119791. [DOI] [PubMed] [Google Scholar]
  6. Field E. J., Joyce G., Smith B. M. Erythrocyte-UFA (Eufa) mobility test for multiple sclerosis: implications for pathogenesis and handling of the disease. J Neurol. 1977 Jan 13;214(2):113–127. doi: 10.1007/BF02430349. [DOI] [PubMed] [Google Scholar]
  7. Galli C., White H. B., Jr, Paoletti R. Brain lipid modifications induced by essential fatty acid deficiency in growing male and female rats. J Neurochem. 1970 Mar;17(3):347–355. doi: 10.1111/j.1471-4159.1970.tb02221.x. [DOI] [PubMed] [Google Scholar]
  8. Gul S., Smith A. D., Thompson R. H., Wright H. P., Zilkha K. J. Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):506–510. doi: 10.1136/jnnp.33.4.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hawkins S. A., Millar J. H. Erythrocyte electrophoretic mobility test for multiple sclerosis. Lancet. 1979 Jan 20;1(8108):165–166. doi: 10.1016/s0140-6736(79)90567-1. [DOI] [PubMed] [Google Scholar]
  10. Love W. C., Cashell A., Reynolds M., Callaghan N. Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases. Br Med J. 1974 Jul 6;3(5922):18–21. doi: 10.1136/bmj.3.5922.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mertin J., Meade C. J. Relevance of fatty acids in multiple sclerosis. Br Med Bull. 1977 Jan;33(1):67–71. doi: 10.1093/oxfordjournals.bmb.a071399. [DOI] [PubMed] [Google Scholar]
  12. Millar J. H., Zilkha K. J., Langman M. J., Wright H. P., Smith A. D., Belin J., Thompson R. H. Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J. 1973 Mar 31;1(5856):765–768. doi: 10.1136/bmj.1.5856.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paty D. W., Cousin H. K., Read S., Adlakha K. Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neurol Scand. 1978 Jul;58(1):53–58. doi: 10.1111/j.1600-0404.1978.tb02859.x. [DOI] [PubMed] [Google Scholar]
  14. Seaman G. V., Swank R. L., Tamblyn C. H., Zukoski C. F., 4th Simplified red-cell electrophoretic mobility test for multiple sclerosis. Lancet. 1979 May 26;1(8126):1138–1139. doi: 10.1016/s0140-6736(79)91813-0. [DOI] [PubMed] [Google Scholar]
  15. Shukla V. K., Clausen J. Linoleate and fatty acid patterns of serum lipids in multiple sclerosis. Acta Neurol Scand. 1978 Mar;57(3):270–274. doi: 10.1111/j.1600-0404.1978.tb05875.x. [DOI] [PubMed] [Google Scholar]
  16. Stoof J. C., Vrijmoed-de Vries M. C., Koetsier J. C., Langevoort H. L. Evaluation of the red blood cell cytopherometric test for the diagnosis of multiple sclerosis. Acta Neurol Scand. 1977 Aug;56(2):170–176. doi: 10.1111/j.1600-0404.1977.tb01421.x. [DOI] [PubMed] [Google Scholar]
  17. Thompson R. H. A biochemical approach to the problem of multiple sclerosis. Proc R Soc Med. 1966 Mar;59(3):269–276. doi: 10.1177/003591576605900332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tsang W. M., Belin J., Monro J. A., Smith A. D., Thompson R. H., Zilkha K. J. Relationship between plasma and lymphocyte linoleate in multiple sclerosis. J Neurol Neurosurg Psychiatry. 1976 Aug;39(8):767–771. doi: 10.1136/jnnp.39.8.767. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES